Detailed Baseline Demographics and Disease Characteristics of Patients with Geographic Atrophy Enrolled in the Phase 3 OAKS and DERBY Clinical Trials…and Why it Matters! (ASRS 2022) - Apellis Medical Hub

Home / Congress Presentations / Geographic Atrophy / ASRS 2022

Detailed Baseline Demographics and Disease Characteristics of Patients with Geographic Atrophy Enrolled in the Phase 3 OAKS and DERBY Clinical Trials…and Why it Matters!

Share Via Email

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.